nodes	percent_of_prediction	percent_of_DWPC	metapath
Dalfampridine—CYP2E1—lung cancer	0.353	1	CbGaD
Dalfampridine—KCNB1—pulmonary artery—lung cancer	0.0319	0.192	CbGeAlD
Dalfampridine—KCNA5—pulmonary artery—lung cancer	0.021	0.126	CbGeAlD
Dalfampridine—KCNS3—pulmonary artery—lung cancer	0.0205	0.123	CbGeAlD
Dalfampridine—KCNA10—respiratory system—lung cancer	0.00964	0.0579	CbGeAlD
Dalfampridine—KCNA10—lung—lung cancer	0.00512	0.0308	CbGeAlD
Dalfampridine—KCNB1—epithelium—lung cancer	0.00448	0.0269	CbGeAlD
Dalfampridine—KCNC3—epithelium—lung cancer	0.00435	0.0261	CbGeAlD
Dalfampridine—KCNS1—epithelium—lung cancer	0.00403	0.0242	CbGeAlD
Dalfampridine—KCNF1—bronchus—lung cancer	0.00325	0.0195	CbGeAlD
Dalfampridine—KCNA5—bronchus—lung cancer	0.0029	0.0174	CbGeAlD
Dalfampridine—KCNS3—epithelium—lung cancer	0.00289	0.0173	CbGeAlD
Dalfampridine—KCNS3—bronchus—lung cancer	0.00284	0.0171	CbGeAlD
Dalfampridine—KCNA3—lung—lung cancer	0.00269	0.0162	CbGeAlD
Dalfampridine—KCND3—respiratory system—lung cancer	0.00263	0.0158	CbGeAlD
Dalfampridine—KCNA5—trachea—lung cancer	0.00261	0.0157	CbGeAlD
Dalfampridine—KCNS3—trachea—lung cancer	0.00255	0.0153	CbGeAlD
Dalfampridine—KCNQ1—respiratory system—lung cancer	0.00254	0.0153	CbGeAlD
Dalfampridine—KCNA5—cardiac atrium—lung cancer	0.00245	0.0147	CbGeAlD
Dalfampridine—KCND1—lung—lung cancer	0.00245	0.0147	CbGeAlD
Dalfampridine—KCNC4—lung—lung cancer	0.00245	0.0147	CbGeAlD
Dalfampridine—KCNF1—lung—lung cancer	0.00209	0.0126	CbGeAlD
Dalfampridine—KCNQ1—bronchus—lung cancer	0.00209	0.0126	CbGeAlD
Dalfampridine—KCNA5—lung—lung cancer	0.00187	0.0113	CbGeAlD
Dalfampridine—KCNA3—lymph node—lung cancer	0.00184	0.011	CbGeAlD
Dalfampridine—KCNS3—lung—lung cancer	0.00183	0.011	CbGeAlD
Dalfampridine—KCNQ3—lung—lung cancer	0.00183	0.011	CbGeAlD
Dalfampridine—KCND3—cardiac atrium—lung cancer	0.00182	0.0109	CbGeAlD
Dalfampridine—KCNQ1—cardiac atrium—lung cancer	0.00176	0.0106	CbGeAlD
Dalfampridine—KCNA2—lymph node—lung cancer	0.00175	0.0105	CbGeAlD
Dalfampridine—KCNH6—lung—lung cancer	0.00167	0.0101	CbGeAlD
Dalfampridine—KCNC4—lymph node—lung cancer	0.00167	0.0101	CbGeAlD
Dalfampridine—KCNQ5—lymph node—lung cancer	0.00156	0.00939	CbGeAlD
Dalfampridine—KCNQ1—bone marrow—lung cancer	0.00149	0.00895	CbGeAlD
Dalfampridine—KCND3—lung—lung cancer	0.00139	0.00837	CbGeAlD
Dalfampridine—KCNQ1—lung—lung cancer	0.00135	0.00811	CbGeAlD
Dalfampridine—KCNA5—lymph node—lung cancer	0.00128	0.0077	CbGeAlD
Dalfampridine—KCNS3—lymph node—lung cancer	0.00125	0.00754	CbGeAlD
Dalfampridine—KCND3—lymph node—lung cancer	0.000953	0.00573	CbGeAlD
Dalfampridine—KCNQ1—lymph node—lung cancer	0.000923	0.00555	CbGeAlD
Dalfampridine—CYP2E1—respiratory system—lung cancer	0.000746	0.00448	CbGeAlD
Dalfampridine—KCNH2—cardiac atrium—lung cancer	0.000673	0.00404	CbGeAlD
Dalfampridine—KCNH2—bone marrow—lung cancer	0.000568	0.00341	CbGeAlD
Dalfampridine—Infestation NOS—Docetaxel—lung cancer	0.000547	0.0023	CcSEcCtD
Dalfampridine—Infestation—Docetaxel—lung cancer	0.000547	0.0023	CcSEcCtD
Dalfampridine—Dyspnoea—Vinorelbine—lung cancer	0.000545	0.00229	CcSEcCtD
Dalfampridine—Hypersensitivity—Vinblastine—lung cancer	0.000542	0.00228	CcSEcCtD
Dalfampridine—Angiopathy—Etoposide—lung cancer	0.000536	0.00225	CcSEcCtD
Dalfampridine—Immune system disorder—Etoposide—lung cancer	0.000533	0.00224	CcSEcCtD
Dalfampridine—Mediastinal disorder—Etoposide—lung cancer	0.000532	0.00224	CcSEcCtD
Dalfampridine—Asthenia—Vinblastine—lung cancer	0.000528	0.00222	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000528	0.00222	CcSEcCtD
Dalfampridine—Hypersensitivity—Topotecan—lung cancer	0.000527	0.00222	CcSEcCtD
Dalfampridine—Tremor—Cisplatin—lung cancer	0.000526	0.00221	CcSEcCtD
Dalfampridine—Angiopathy—Paclitaxel—lung cancer	0.000525	0.00221	CcSEcCtD
Dalfampridine—Constipation—Vinorelbine—lung cancer	0.000523	0.0022	CcSEcCtD
Dalfampridine—Immune system disorder—Paclitaxel—lung cancer	0.000523	0.0022	CcSEcCtD
Dalfampridine—Mediastinal disorder—Paclitaxel—lung cancer	0.000522	0.0022	CcSEcCtD
Dalfampridine—Asthenia—Topotecan—lung cancer	0.000513	0.00216	CcSEcCtD
Dalfampridine—Chest pain—Gemcitabine—lung cancer	0.000513	0.00216	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—lung cancer	0.000509	0.00214	CcSEcCtD
Dalfampridine—Confusional state—Irinotecan—lung cancer	0.000509	0.00214	CcSEcCtD
Dalfampridine—Asthenia—Erlotinib—lung cancer	0.000508	0.00214	CcSEcCtD
Dalfampridine—Mental disorder—Paclitaxel—lung cancer	0.000507	0.00213	CcSEcCtD
Dalfampridine—Anaphylactic shock—Irinotecan—lung cancer	0.000504	0.00212	CcSEcCtD
Dalfampridine—Feeling abnormal—Vinorelbine—lung cancer	0.000504	0.00212	CcSEcCtD
Dalfampridine—Infection—Irinotecan—lung cancer	0.000501	0.00211	CcSEcCtD
Dalfampridine—Back pain—Etoposide—lung cancer	0.000497	0.00209	CcSEcCtD
Dalfampridine—Nervous system disorder—Irinotecan—lung cancer	0.000495	0.00208	CcSEcCtD
Dalfampridine—Anaphylactic shock—Gemcitabine—lung cancer	0.000491	0.00207	CcSEcCtD
Dalfampridine—Infection—Gemcitabine—lung cancer	0.000488	0.00205	CcSEcCtD
Dalfampridine—Back pain—Paclitaxel—lung cancer	0.000488	0.00205	CcSEcCtD
Dalfampridine—Dizziness—Vinblastine—lung cancer	0.000487	0.00205	CcSEcCtD
Dalfampridine—Convulsion—Cisplatin—lung cancer	0.000486	0.00205	CcSEcCtD
Dalfampridine—Urticaria—Vinorelbine—lung cancer	0.000486	0.00204	CcSEcCtD
Dalfampridine—Connective tissue disorder—Docetaxel—lung cancer	0.000482	0.00203	CcSEcCtD
Dalfampridine—Nervous system disorder—Gemcitabine—lung cancer	0.000482	0.00203	CcSEcCtD
Dalfampridine—Skin disorder—Gemcitabine—lung cancer	0.000477	0.00201	CcSEcCtD
Dalfampridine—Anxiety—Cisplatin—lung cancer	0.000476	0.002	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.000474	0.002	CcSEcCtD
Dalfampridine—Dizziness—Topotecan—lung cancer	0.000473	0.00199	CcSEcCtD
Dalfampridine—Tremor—Paclitaxel—lung cancer	0.000472	0.00199	CcSEcCtD
Dalfampridine—Hypotension—Irinotecan—lung cancer	0.000471	0.00198	CcSEcCtD
Dalfampridine—Vomiting—Vinblastine—lung cancer	0.000468	0.00197	CcSEcCtD
Dalfampridine—Dizziness—Erlotinib—lung cancer	0.000468	0.00197	CcSEcCtD
Dalfampridine—Headache—Vinblastine—lung cancer	0.000461	0.00194	CcSEcCtD
Dalfampridine—Angioedema—Paclitaxel—lung cancer	0.000461	0.00194	CcSEcCtD
Dalfampridine—Hypotension—Gemcitabine—lung cancer	0.000459	0.00193	CcSEcCtD
Dalfampridine—Anaphylactic shock—Cisplatin—lung cancer	0.000458	0.00193	CcSEcCtD
Dalfampridine—Insomnia—Irinotecan—lung cancer	0.000456	0.00192	CcSEcCtD
Dalfampridine—Infection—Cisplatin—lung cancer	0.000455	0.00191	CcSEcCtD
Dalfampridine—Vomiting—Topotecan—lung cancer	0.000455	0.00191	CcSEcCtD
Dalfampridine—Paraesthesia—Irinotecan—lung cancer	0.000453	0.00191	CcSEcCtD
Dalfampridine—Rash—Topotecan—lung cancer	0.000451	0.0019	CcSEcCtD
Dalfampridine—Hypersensitivity—Vinorelbine—lung cancer	0.000451	0.0019	CcSEcCtD
Dalfampridine—Dermatitis—Topotecan—lung cancer	0.00045	0.00189	CcSEcCtD
Dalfampridine—Vomiting—Erlotinib—lung cancer	0.00045	0.00189	CcSEcCtD
Dalfampridine—Dyspnoea—Irinotecan—lung cancer	0.00045	0.00189	CcSEcCtD
Dalfampridine—Nervous system disorder—Cisplatin—lung cancer	0.000449	0.00189	CcSEcCtD
Dalfampridine—Headache—Topotecan—lung cancer	0.000448	0.00188	CcSEcCtD
Dalfampridine—Rash—Erlotinib—lung cancer	0.000446	0.00188	CcSEcCtD
Dalfampridine—Dermatitis—Erlotinib—lung cancer	0.000446	0.00187	CcSEcCtD
Dalfampridine—Convulsion—Etoposide—lung cancer	0.000445	0.00187	CcSEcCtD
Dalfampridine—Angiopathy—Docetaxel—lung cancer	0.000445	0.00187	CcSEcCtD
Dalfampridine—Skin disorder—Cisplatin—lung cancer	0.000445	0.00187	CcSEcCtD
Dalfampridine—Insomnia—Gemcitabine—lung cancer	0.000444	0.00187	CcSEcCtD
Dalfampridine—Dyspepsia—Irinotecan—lung cancer	0.000444	0.00187	CcSEcCtD
Dalfampridine—Immune system disorder—Docetaxel—lung cancer	0.000443	0.00187	CcSEcCtD
Dalfampridine—Headache—Erlotinib—lung cancer	0.000443	0.00186	CcSEcCtD
Dalfampridine—Mediastinal disorder—Docetaxel—lung cancer	0.000442	0.00186	CcSEcCtD
Dalfampridine—Paraesthesia—Gemcitabine—lung cancer	0.000441	0.00186	CcSEcCtD
Dalfampridine—Asthenia—Vinorelbine—lung cancer	0.000439	0.00185	CcSEcCtD
Dalfampridine—Dyspnoea—Gemcitabine—lung cancer	0.000438	0.00184	CcSEcCtD
Dalfampridine—Chest pain—Etoposide—lung cancer	0.000438	0.00184	CcSEcCtD
Dalfampridine—Nausea—Vinblastine—lung cancer	0.000437	0.00184	CcSEcCtD
Dalfampridine—Convulsion—Paclitaxel—lung cancer	0.000437	0.00184	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000435	0.00183	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000435	0.00183	CcSEcCtD
Dalfampridine—Constipation—Irinotecan—lung cancer	0.000431	0.00181	CcSEcCtD
Dalfampridine—Mental disorder—Docetaxel—lung cancer	0.00043	0.00181	CcSEcCtD
Dalfampridine—Chest pain—Paclitaxel—lung cancer	0.000429	0.00181	CcSEcCtD
Dalfampridine—Hypotension—Cisplatin—lung cancer	0.000428	0.0018	CcSEcCtD
Dalfampridine—Anxiety—Paclitaxel—lung cancer	0.000428	0.0018	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000426	0.00179	CcSEcCtD
Dalfampridine—Nausea—Topotecan—lung cancer	0.000425	0.00179	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000424	0.00178	CcSEcCtD
Dalfampridine—Confusional state—Etoposide—lung cancer	0.000423	0.00178	CcSEcCtD
Dalfampridine—Constipation—Gemcitabine—lung cancer	0.00042	0.00177	CcSEcCtD
Dalfampridine—Nausea—Erlotinib—lung cancer	0.00042	0.00177	CcSEcCtD
Dalfampridine—Anaphylactic shock—Etoposide—lung cancer	0.00042	0.00177	CcSEcCtD
Dalfampridine—Infection—Etoposide—lung cancer	0.000417	0.00175	CcSEcCtD
Dalfampridine—Feeling abnormal—Irinotecan—lung cancer	0.000416	0.00175	CcSEcCtD
Dalfampridine—Confusional state—Paclitaxel—lung cancer	0.000415	0.00175	CcSEcCtD
Dalfampridine—Back pain—Docetaxel—lung cancer	0.000413	0.00174	CcSEcCtD
Dalfampridine—Anaphylactic shock—Paclitaxel—lung cancer	0.000411	0.00173	CcSEcCtD
Dalfampridine—Paraesthesia—Cisplatin—lung cancer	0.000411	0.00173	CcSEcCtD
Dalfampridine—Infection—Paclitaxel—lung cancer	0.000409	0.00172	CcSEcCtD
Dalfampridine—Dyspnoea—Cisplatin—lung cancer	0.000408	0.00172	CcSEcCtD
Dalfampridine—Skin disorder—Etoposide—lung cancer	0.000408	0.00171	CcSEcCtD
Dalfampridine—Feeling abnormal—Gemcitabine—lung cancer	0.000405	0.0017	CcSEcCtD
Dalfampridine—Dizziness—Vinorelbine—lung cancer	0.000404	0.0017	CcSEcCtD
Dalfampridine—Nervous system disorder—Paclitaxel—lung cancer	0.000403	0.0017	CcSEcCtD
Dalfampridine—Skin disorder—Paclitaxel—lung cancer	0.0004	0.00168	CcSEcCtD
Dalfampridine—CYP2E1—lung—lung cancer	0.000396	0.00238	CbGeAlD
Dalfampridine—Nasopharyngitis—Doxorubicin—lung cancer	0.000396	0.00167	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000395	0.00166	CcSEcCtD
Dalfampridine—Infestation NOS—Methotrexate—lung cancer	0.000394	0.00166	CcSEcCtD
Dalfampridine—Infestation—Methotrexate—lung cancer	0.000394	0.00166	CcSEcCtD
Dalfampridine—Hypotension—Etoposide—lung cancer	0.000392	0.00165	CcSEcCtD
Dalfampridine—Vomiting—Vinorelbine—lung cancer	0.000389	0.00164	CcSEcCtD
Dalfampridine—Rash—Vinorelbine—lung cancer	0.000386	0.00162	CcSEcCtD
Dalfampridine—Dermatitis—Vinorelbine—lung cancer	0.000385	0.00162	CcSEcCtD
Dalfampridine—Hypotension—Paclitaxel—lung cancer	0.000384	0.00162	CcSEcCtD
Dalfampridine—Headache—Vinorelbine—lung cancer	0.000383	0.00161	CcSEcCtD
Dalfampridine—Feeling abnormal—Cisplatin—lung cancer	0.000377	0.00159	CcSEcCtD
Dalfampridine—Paraesthesia—Etoposide—lung cancer	0.000377	0.00159	CcSEcCtD
Dalfampridine—Dyspnoea—Etoposide—lung cancer	0.000374	0.00157	CcSEcCtD
Dalfampridine—Insomnia—Paclitaxel—lung cancer	0.000372	0.00157	CcSEcCtD
Dalfampridine—Hypersensitivity—Irinotecan—lung cancer	0.000372	0.00156	CcSEcCtD
Dalfampridine—Convulsion—Docetaxel—lung cancer	0.00037	0.00156	CcSEcCtD
Dalfampridine—Paraesthesia—Paclitaxel—lung cancer	0.000369	0.00155	CcSEcCtD
Dalfampridine—Dyspnoea—Paclitaxel—lung cancer	0.000367	0.00154	CcSEcCtD
Dalfampridine—Chest pain—Docetaxel—lung cancer	0.000364	0.00153	CcSEcCtD
Dalfampridine—Nausea—Vinorelbine—lung cancer	0.000363	0.00153	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Etoposide—lung cancer	0.000362	0.00152	CcSEcCtD
Dalfampridine—Dyspepsia—Paclitaxel—lung cancer	0.000362	0.00152	CcSEcCtD
Dalfampridine—Asthenia—Irinotecan—lung cancer	0.000362	0.00152	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000361	0.00152	CcSEcCtD
Dalfampridine—Constipation—Etoposide—lung cancer	0.000359	0.00151	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000355	0.00149	CcSEcCtD
Dalfampridine—Asthenia—Gemcitabine—lung cancer	0.000353	0.00148	CcSEcCtD
Dalfampridine—KCNH2—lymph node—lung cancer	0.000352	0.00211	CbGeAlD
Dalfampridine—Constipation—Paclitaxel—lung cancer	0.000352	0.00148	CcSEcCtD
Dalfampridine—Confusional state—Docetaxel—lung cancer	0.000352	0.00148	CcSEcCtD
Dalfampridine—Anaphylactic shock—Docetaxel—lung cancer	0.000349	0.00147	CcSEcCtD
Dalfampridine—Infection—Docetaxel—lung cancer	0.000346	0.00146	CcSEcCtD
Dalfampridine—Feeling abnormal—Etoposide—lung cancer	0.000346	0.00145	CcSEcCtD
Dalfampridine—Nervous system disorder—Docetaxel—lung cancer	0.000342	0.00144	CcSEcCtD
Dalfampridine—Infestation NOS—Doxorubicin—lung cancer	0.000341	0.00144	CcSEcCtD
Dalfampridine—Infestation—Doxorubicin—lung cancer	0.000341	0.00144	CcSEcCtD
Dalfampridine—Feeling abnormal—Paclitaxel—lung cancer	0.000339	0.00143	CcSEcCtD
Dalfampridine—Skin disorder—Docetaxel—lung cancer	0.000339	0.00143	CcSEcCtD
Dalfampridine—Hypersensitivity—Cisplatin—lung cancer	0.000337	0.00142	CcSEcCtD
Dalfampridine—Dizziness—Irinotecan—lung cancer	0.000334	0.0014	CcSEcCtD
Dalfampridine—Urticaria—Etoposide—lung cancer	0.000333	0.0014	CcSEcCtD
Dalfampridine—Urinary tract infection—Doxorubicin—lung cancer	0.000332	0.0014	CcSEcCtD
Dalfampridine—Asthenia—Cisplatin—lung cancer	0.000329	0.00138	CcSEcCtD
Dalfampridine—Urticaria—Paclitaxel—lung cancer	0.000327	0.00138	CcSEcCtD
Dalfampridine—Hypotension—Docetaxel—lung cancer	0.000326	0.00137	CcSEcCtD
Dalfampridine—Angiopathy—Methotrexate—lung cancer	0.000321	0.00135	CcSEcCtD
Dalfampridine—Vomiting—Irinotecan—lung cancer	0.000321	0.00135	CcSEcCtD
Dalfampridine—Immune system disorder—Methotrexate—lung cancer	0.00032	0.00134	CcSEcCtD
Dalfampridine—Mediastinal disorder—Methotrexate—lung cancer	0.000319	0.00134	CcSEcCtD
Dalfampridine—Rash—Irinotecan—lung cancer	0.000318	0.00134	CcSEcCtD
Dalfampridine—Dermatitis—Irinotecan—lung cancer	0.000318	0.00134	CcSEcCtD
Dalfampridine—Headache—Irinotecan—lung cancer	0.000316	0.00133	CcSEcCtD
Dalfampridine—Insomnia—Docetaxel—lung cancer	0.000315	0.00133	CcSEcCtD
Dalfampridine—Paraesthesia—Docetaxel—lung cancer	0.000313	0.00132	CcSEcCtD
Dalfampridine—Vomiting—Gemcitabine—lung cancer	0.000312	0.00131	CcSEcCtD
Dalfampridine—Dyspnoea—Docetaxel—lung cancer	0.000311	0.00131	CcSEcCtD
Dalfampridine—Mental disorder—Methotrexate—lung cancer	0.00031	0.0013	CcSEcCtD
Dalfampridine—Rash—Gemcitabine—lung cancer	0.00031	0.0013	CcSEcCtD
Dalfampridine—Dermatitis—Gemcitabine—lung cancer	0.00031	0.0013	CcSEcCtD
Dalfampridine—Hypersensitivity—Etoposide—lung cancer	0.000309	0.0013	CcSEcCtD
Dalfampridine—Headache—Gemcitabine—lung cancer	0.000308	0.0013	CcSEcCtD
Dalfampridine—Dyspepsia—Docetaxel—lung cancer	0.000307	0.00129	CcSEcCtD
Dalfampridine—Hypersensitivity—Paclitaxel—lung cancer	0.000303	0.00128	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000301	0.00127	CcSEcCtD
Dalfampridine—Asthenia—Etoposide—lung cancer	0.000301	0.00127	CcSEcCtD
Dalfampridine—Connective tissue disorder—Doxorubicin—lung cancer	0.000301	0.00127	CcSEcCtD
Dalfampridine—Nausea—Irinotecan—lung cancer	0.0003	0.00126	CcSEcCtD
Dalfampridine—Constipation—Docetaxel—lung cancer	0.000298	0.00125	CcSEcCtD
Dalfampridine—Back pain—Methotrexate—lung cancer	0.000298	0.00125	CcSEcCtD
Dalfampridine—Asthenia—Paclitaxel—lung cancer	0.000295	0.00124	CcSEcCtD
Dalfampridine—Nausea—Gemcitabine—lung cancer	0.000292	0.00123	CcSEcCtD
Dalfampridine—Vomiting—Cisplatin—lung cancer	0.000291	0.00123	CcSEcCtD
Dalfampridine—Rash—Cisplatin—lung cancer	0.000289	0.00121	CcSEcCtD
Dalfampridine—Dermatitis—Cisplatin—lung cancer	0.000288	0.00121	CcSEcCtD
Dalfampridine—Feeling abnormal—Docetaxel—lung cancer	0.000287	0.00121	CcSEcCtD
Dalfampridine—Angiopathy—Doxorubicin—lung cancer	0.000278	0.00117	CcSEcCtD
Dalfampridine—Dizziness—Etoposide—lung cancer	0.000277	0.00117	CcSEcCtD
Dalfampridine—Immune system disorder—Doxorubicin—lung cancer	0.000277	0.00116	CcSEcCtD
Dalfampridine—Mediastinal disorder—Doxorubicin—lung cancer	0.000276	0.00116	CcSEcCtD
Dalfampridine—Dizziness—Paclitaxel—lung cancer	0.000272	0.00114	CcSEcCtD
Dalfampridine—Nausea—Cisplatin—lung cancer	0.000272	0.00114	CcSEcCtD
Dalfampridine—Mental disorder—Doxorubicin—lung cancer	0.000268	0.00113	CcSEcCtD
Dalfampridine—Convulsion—Methotrexate—lung cancer	0.000267	0.00112	CcSEcCtD
Dalfampridine—Vomiting—Etoposide—lung cancer	0.000267	0.00112	CcSEcCtD
Dalfampridine—Rash—Etoposide—lung cancer	0.000265	0.00111	CcSEcCtD
Dalfampridine—Dermatitis—Etoposide—lung cancer	0.000264	0.00111	CcSEcCtD
Dalfampridine—Headache—Etoposide—lung cancer	0.000263	0.00111	CcSEcCtD
Dalfampridine—Chest pain—Methotrexate—lung cancer	0.000262	0.0011	CcSEcCtD
Dalfampridine—Vomiting—Paclitaxel—lung cancer	0.000262	0.0011	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00026	0.0011	CcSEcCtD
Dalfampridine—Rash—Paclitaxel—lung cancer	0.000259	0.00109	CcSEcCtD
Dalfampridine—Dermatitis—Paclitaxel—lung cancer	0.000259	0.00109	CcSEcCtD
Dalfampridine—Back pain—Doxorubicin—lung cancer	0.000258	0.00109	CcSEcCtD
Dalfampridine—Headache—Paclitaxel—lung cancer	0.000258	0.00108	CcSEcCtD
Dalfampridine—Hypersensitivity—Docetaxel—lung cancer	0.000257	0.00108	CcSEcCtD
Dalfampridine—Confusional state—Methotrexate—lung cancer	0.000253	0.00107	CcSEcCtD
Dalfampridine—Anaphylactic shock—Methotrexate—lung cancer	0.000251	0.00106	CcSEcCtD
Dalfampridine—Asthenia—Docetaxel—lung cancer	0.00025	0.00105	CcSEcCtD
Dalfampridine—Infection—Methotrexate—lung cancer	0.00025	0.00105	CcSEcCtD
Dalfampridine—Nausea—Etoposide—lung cancer	0.000249	0.00105	CcSEcCtD
Dalfampridine—Nervous system disorder—Methotrexate—lung cancer	0.000246	0.00104	CcSEcCtD
Dalfampridine—Nausea—Paclitaxel—lung cancer	0.000244	0.00103	CcSEcCtD
Dalfampridine—Skin disorder—Methotrexate—lung cancer	0.000244	0.00103	CcSEcCtD
Dalfampridine—Hypotension—Methotrexate—lung cancer	0.000235	0.000988	CcSEcCtD
Dalfampridine—Convulsion—Doxorubicin—lung cancer	0.000231	0.000972	CcSEcCtD
Dalfampridine—Dizziness—Docetaxel—lung cancer	0.000231	0.00097	CcSEcCtD
Dalfampridine—Insomnia—Methotrexate—lung cancer	0.000227	0.000956	CcSEcCtD
Dalfampridine—Chest pain—Doxorubicin—lung cancer	0.000227	0.000955	CcSEcCtD
Dalfampridine—Anxiety—Doxorubicin—lung cancer	0.000226	0.000952	CcSEcCtD
Dalfampridine—Paraesthesia—Methotrexate—lung cancer	0.000226	0.000949	CcSEcCtD
Dalfampridine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000225	0.000949	CcSEcCtD
Dalfampridine—Dyspnoea—Methotrexate—lung cancer	0.000224	0.000943	CcSEcCtD
Dalfampridine—Vomiting—Docetaxel—lung cancer	0.000222	0.000933	CcSEcCtD
Dalfampridine—Dyspepsia—Methotrexate—lung cancer	0.000221	0.000931	CcSEcCtD
Dalfampridine—Rash—Docetaxel—lung cancer	0.00022	0.000925	CcSEcCtD
Dalfampridine—Dermatitis—Docetaxel—lung cancer	0.00022	0.000924	CcSEcCtD
Dalfampridine—Confusional state—Doxorubicin—lung cancer	0.000219	0.000923	CcSEcCtD
Dalfampridine—Headache—Docetaxel—lung cancer	0.000218	0.000919	CcSEcCtD
Dalfampridine—Anaphylactic shock—Doxorubicin—lung cancer	0.000218	0.000916	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000217	0.000913	CcSEcCtD
Dalfampridine—Infection—Doxorubicin—lung cancer	0.000216	0.00091	CcSEcCtD
Dalfampridine—Nervous system disorder—Doxorubicin—lung cancer	0.000213	0.000898	CcSEcCtD
Dalfampridine—Skin disorder—Doxorubicin—lung cancer	0.000211	0.000889	CcSEcCtD
Dalfampridine—Nausea—Docetaxel—lung cancer	0.000207	0.000871	CcSEcCtD
Dalfampridine—Feeling abnormal—Methotrexate—lung cancer	0.000207	0.000871	CcSEcCtD
Dalfampridine—Hypotension—Doxorubicin—lung cancer	0.000203	0.000856	CcSEcCtD
Dalfampridine—Urticaria—Methotrexate—lung cancer	0.0002	0.00084	CcSEcCtD
Dalfampridine—Insomnia—Doxorubicin—lung cancer	0.000197	0.000828	CcSEcCtD
Dalfampridine—Paraesthesia—Doxorubicin—lung cancer	0.000195	0.000822	CcSEcCtD
Dalfampridine—Dyspnoea—Doxorubicin—lung cancer	0.000194	0.000816	CcSEcCtD
Dalfampridine—Dyspepsia—Doxorubicin—lung cancer	0.000192	0.000806	CcSEcCtD
Dalfampridine—Gastrointestinal disorder—Doxorubicin—lung cancer	0.000188	0.00079	CcSEcCtD
Dalfampridine—Constipation—Doxorubicin—lung cancer	0.000186	0.000783	CcSEcCtD
Dalfampridine—Hypersensitivity—Methotrexate—lung cancer	0.000185	0.000779	CcSEcCtD
Dalfampridine—Asthenia—Methotrexate—lung cancer	0.00018	0.000759	CcSEcCtD
Dalfampridine—Feeling abnormal—Doxorubicin—lung cancer	0.000179	0.000755	CcSEcCtD
Dalfampridine—Urticaria—Doxorubicin—lung cancer	0.000173	0.000727	CcSEcCtD
Dalfampridine—Dizziness—Methotrexate—lung cancer	0.000166	0.000699	CcSEcCtD
Dalfampridine—Hypersensitivity—Doxorubicin—lung cancer	0.00016	0.000675	CcSEcCtD
Dalfampridine—Vomiting—Methotrexate—lung cancer	0.00016	0.000672	CcSEcCtD
Dalfampridine—Rash—Methotrexate—lung cancer	0.000158	0.000667	CcSEcCtD
Dalfampridine—Dermatitis—Methotrexate—lung cancer	0.000158	0.000666	CcSEcCtD
Dalfampridine—Headache—Methotrexate—lung cancer	0.000157	0.000662	CcSEcCtD
Dalfampridine—Asthenia—Doxorubicin—lung cancer	0.000156	0.000657	CcSEcCtD
Dalfampridine—Nausea—Methotrexate—lung cancer	0.000149	0.000628	CcSEcCtD
Dalfampridine—Dizziness—Doxorubicin—lung cancer	0.000144	0.000605	CcSEcCtD
Dalfampridine—Vomiting—Doxorubicin—lung cancer	0.000138	0.000582	CcSEcCtD
Dalfampridine—Rash—Doxorubicin—lung cancer	0.000137	0.000577	CcSEcCtD
Dalfampridine—Dermatitis—Doxorubicin—lung cancer	0.000137	0.000577	CcSEcCtD
Dalfampridine—Headache—Doxorubicin—lung cancer	0.000136	0.000574	CcSEcCtD
Dalfampridine—Nausea—Doxorubicin—lung cancer	0.000129	0.000544	CcSEcCtD
Dalfampridine—KCNG2—Metabolism—ENO1—lung cancer	7.53e-05	0.00031	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ENO1—lung cancer	7.53e-05	0.00031	CbGpPWpGaD
Dalfampridine—CYP2E1—Tryptophan metabolism—MDM2—lung cancer	7.3e-05	0.0003	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6R—lung cancer	7.16e-05	0.000294	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CREBBP—lung cancer	7.15e-05	0.000294	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ENO1—lung cancer	7.14e-05	0.000294	CbGpPWpGaD
Dalfampridine—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	7.14e-05	0.000293	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—FGFR1—lung cancer	7.09e-05	0.000292	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—FGFR1—lung cancer	7.09e-05	0.000292	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—HPGDS—lung cancer	7.04e-05	0.000289	CbGpPWpGaD
Dalfampridine—KCND2—Circadian rythm related genes—IL6—lung cancer	7.03e-05	0.000289	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTT1—lung cancer	6.83e-05	0.000281	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—RAF1—lung cancer	6.77e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—RAF1—lung cancer	6.77e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP2E1—lung cancer	6.75e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP2E1—lung cancer	6.75e-05	0.000278	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP2E1—lung cancer	6.75e-05	0.000278	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP2A6—lung cancer	6.75e-05	0.000277	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GCLC—lung cancer	6.75e-05	0.000277	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—TP53—lung cancer	6.72e-05	0.000276	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—ERBB2—lung cancer	6.7e-05	0.000276	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—ERBB2—lung cancer	6.7e-05	0.000276	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KDR—lung cancer	6.68e-05	0.000275	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KDR—lung cancer	6.68e-05	0.000275	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—NQO1—lung cancer	6.68e-05	0.000275	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—NQO1—lung cancer	6.68e-05	0.000275	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—NQO1—lung cancer	6.68e-05	0.000275	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MET—lung cancer	6.54e-05	0.000269	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MET—lung cancer	6.54e-05	0.000269	CbGpPWpGaD
Dalfampridine—KCNG2—Neuronal System—HRAS—lung cancer	6.52e-05	0.000268	CbGpPWpGaD
Dalfampridine—KCNC2—Neuronal System—HRAS—lung cancer	6.52e-05	0.000268	CbGpPWpGaD
Dalfampridine—KCNS3—Neuronal System—HRAS—lung cancer	6.52e-05	0.000268	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP2E1—lung cancer	6.4e-05	0.000263	CbGpPWpGaD
Dalfampridine—KCND3—Neuronal System—HRAS—lung cancer	6.34e-05	0.000261	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—NQO1—lung cancer	6.33e-05	0.00026	CbGpPWpGaD
Dalfampridine—KCNB1—Neuronal System—HRAS—lung cancer	6.18e-05	0.000254	CbGpPWpGaD
Dalfampridine—KCNH7—Circadian rythm related genes—IL6—lung cancer	6.15e-05	0.000253	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—STK11—lung cancer	6.02e-05	0.000248	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—STK11—lung cancer	6.02e-05	0.000248	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—STK11—lung cancer	6.02e-05	0.000248	CbGpPWpGaD
Dalfampridine—CYP2E1—Phase 1 - Functionalization of compounds—POMC—lung cancer	5.78e-05	0.000238	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MMP9—lung cancer	5.75e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MMP9—lung cancer	5.75e-05	0.000236	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6R—lung cancer	5.72e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6R—lung cancer	5.72e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—CREBBP—lung cancer	5.71e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—CREBBP—lung cancer	5.71e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—STK11—lung cancer	5.71e-05	0.000235	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CXCL8—lung cancer	5.68e-05	0.000233	CbGpPWpGaD
Dalfampridine—KCNQ1—Neuronal System—HRAS—lung cancer	5.65e-05	0.000233	CbGpPWpGaD
Dalfampridine—KCND2—Neuronal System—HRAS—lung cancer	5.65e-05	0.000233	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTP1—lung cancer	5.57e-05	0.000229	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTP1—lung cancer	5.57e-05	0.000229	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTP1—lung cancer	5.57e-05	0.000229	CbGpPWpGaD
Dalfampridine—KCNH6—Neuronal System—HRAS—lung cancer	5.54e-05	0.000228	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP2—lung cancer	5.46e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP2—lung cancer	5.46e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAP2K1—lung cancer	5.45e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAP2K1—lung cancer	5.45e-05	0.000224	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—CASP3—lung cancer	5.43e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CAT—lung cancer	5.42e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CAT—lung cancer	5.42e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CAT—lung cancer	5.42e-05	0.000223	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—SRC—lung cancer	5.3e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—SRC—lung cancer	5.3e-05	0.000218	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTP1—lung cancer	5.28e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—JUN—lung cancer	5.28e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ABCB1—lung cancer	5.27e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ABCB1—lung cancer	5.27e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ABCB1—lung cancer	5.27e-05	0.000217	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—TYMS—lung cancer	5.18e-05	0.000213	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—TYMS—lung cancer	5.18e-05	0.000213	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—TYMS—lung cancer	5.18e-05	0.000213	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—VEGFA—lung cancer	5.16e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—VEGFA—lung cancer	5.16e-05	0.000212	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CAT—lung cancer	5.14e-05	0.000211	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—GSTM1—lung cancer	5.12e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—GSTM1—lung cancer	5.12e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—GSTM1—lung cancer	5.12e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—NRAS—lung cancer	5.1e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—NRAS—lung cancer	5.1e-05	0.00021	CbGpPWpGaD
Dalfampridine—KCNA1—Neuronal System—HRAS—lung cancer	5.01e-05	0.000206	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ABCB1—lung cancer	5e-05	0.000206	CbGpPWpGaD
Dalfampridine—KCNH7—Neuronal System—HRAS—lung cancer	4.94e-05	0.000203	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—TYMS—lung cancer	4.91e-05	0.000202	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—MAPK3—lung cancer	4.88e-05	0.000201	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—MAPK3—lung cancer	4.88e-05	0.000201	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—EP300—lung cancer	4.87e-05	0.0002	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—GSTM1—lung cancer	4.85e-05	0.0002	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CYP1A1—lung cancer	4.85e-05	0.0002	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CYP1A1—lung cancer	4.85e-05	0.0002	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CYP1A1—lung cancer	4.85e-05	0.0002	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—RAF1—lung cancer	4.83e-05	0.000199	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—RAF1—lung cancer	4.83e-05	0.000199	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ERCC2—lung cancer	4.81e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ERCC2—lung cancer	4.81e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ERCC2—lung cancer	4.81e-05	0.000198	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—ERBB2—lung cancer	4.78e-05	0.000197	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—ERBB2—lung cancer	4.78e-05	0.000197	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTP1—lung cancer	4.73e-05	0.000195	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTP1—lung cancer	4.67e-05	0.000192	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—EGFR—lung cancer	4.64e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—EGFR—lung cancer	4.64e-05	0.000191	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—VEGFA—lung cancer	4.61e-05	0.00019	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CYP1A1—lung cancer	4.6e-05	0.000189	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ERCC2—lung cancer	4.56e-05	0.000188	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—BRAF—lung cancer	4.55e-05	0.000187	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—KRAS—lung cancer	4.39e-05	0.00018	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—KRAS—lung cancer	4.39e-05	0.00018	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—GSTM1—lung cancer	4.35e-05	0.000179	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—GSTM1—lung cancer	4.29e-05	0.000176	CbGpPWpGaD
Dalfampridine—KCNQ2—Neuronal System—HRAS—lung cancer	4.2e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNQ3—Neuronal System—HRAS—lung cancer	4.2e-05	0.000173	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—APOA1—lung cancer	4.16e-05	0.000171	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—APOA1—lung cancer	4.16e-05	0.000171	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—APOA1—lung cancer	4.16e-05	0.000171	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—CYP1A1—lung cancer	4.12e-05	0.00017	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MMP9—lung cancer	4.1e-05	0.000169	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MMP9—lung cancer	4.1e-05	0.000169	CbGpPWpGaD
Dalfampridine—CYP2E1—Metapathway biotransformation—CYP1A1—lung cancer	4.06e-05	0.000167	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—APOA1—lung cancer	3.95e-05	0.000162	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EP300—lung cancer	3.89e-05	0.00016	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EP300—lung cancer	3.89e-05	0.00016	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—MDM2—lung cancer	3.81e-05	0.000157	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—RAF1—lung cancer	3.8e-05	0.000156	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CG—lung cancer	3.8e-05	0.000156	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CG—lung cancer	3.8e-05	0.000156	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CG—lung cancer	3.8e-05	0.000156	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—SRC—lung cancer	3.78e-05	0.000155	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—SRC—lung cancer	3.78e-05	0.000155	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—HRAS—lung cancer	3.73e-05	0.000153	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—HRAS—lung cancer	3.73e-05	0.000153	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—VEGFA—lung cancer	3.68e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—VEGFA—lung cancer	3.68e-05	0.000151	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—STAT3—lung cancer	3.65e-05	0.00015	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—STAT3—lung cancer	3.65e-05	0.00015	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—NRAS—lung cancer	3.64e-05	0.00015	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—NRAS—lung cancer	3.64e-05	0.00015	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AZIN2—lung cancer	3.63e-05	0.000149	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—COL4A3BP—lung cancer	3.63e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—POMC—lung cancer	3.62e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—POMC—lung cancer	3.62e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—POMC—lung cancer	3.62e-05	0.000149	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CG—lung cancer	3.6e-05	0.000148	CbGpPWpGaD
Dalfampridine—KCNQ3—Axon guidance—IL6—lung cancer	3.57e-05	0.000147	CbGpPWpGaD
Dalfampridine—KCNQ2—Axon guidance—IL6—lung cancer	3.57e-05	0.000147	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—CREBBP—lung cancer	3.52e-05	0.000145	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—CREBBP—lung cancer	3.52e-05	0.000145	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—CREBBP—lung cancer	3.52e-05	0.000145	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—MAPK3—lung cancer	3.48e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—MAPK3—lung cancer	3.48e-05	0.000143	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—POMC—lung cancer	3.43e-05	0.000141	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CD—lung cancer	3.34e-05	0.000137	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CD—lung cancer	3.34e-05	0.000137	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CD—lung cancer	3.34e-05	0.000137	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—CREBBP—lung cancer	3.34e-05	0.000137	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—EGFR—lung cancer	3.31e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—EGFR—lung cancer	3.31e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—ALB—lung cancer	3.3e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—ALB—lung cancer	3.3e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—ALB—lung cancer	3.3e-05	0.000136	CbGpPWpGaD
Dalfampridine—KCNH2—SIDS Susceptibility Pathways—IL6—lung cancer	3.19e-05	0.000131	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CD—lung cancer	3.17e-05	0.00013	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—KRAS—lung cancer	3.13e-05	0.000129	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—KRAS—lung cancer	3.13e-05	0.000129	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—ALB—lung cancer	3.13e-05	0.000129	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ATP5H—lung cancer	3.08e-05	0.000127	CbGpPWpGaD
Dalfampridine—CYP2E1—Biological oxidations—POMC—lung cancer	3.07e-05	0.000126	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CB—lung cancer	2.91e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CB—lung cancer	2.91e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CB—lung cancer	2.91e-05	0.00012	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTGS2—lung cancer	2.88e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTGS2—lung cancer	2.88e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTGS2—lung cancer	2.88e-05	0.000119	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CB—lung cancer	2.76e-05	0.000114	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PLBD1—lung cancer	2.75e-05	0.000113	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTGS2—lung cancer	2.73e-05	0.000112	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—HRAS—lung cancer	2.66e-05	0.000109	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—HRAS—lung cancer	2.66e-05	0.000109	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—IL6—lung cancer	2.55e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—IL6—lung cancer	2.55e-05	0.000105	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PTEN—lung cancer	2.52e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PTEN—lung cancer	2.52e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PTEN—lung cancer	2.52e-05	0.000103	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HSD17B10—lung cancer	2.51e-05	0.000103	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—EP300—lung cancer	2.4e-05	9.87e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—EP300—lung cancer	2.4e-05	9.87e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—EP300—lung cancer	2.4e-05	9.87e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PTEN—lung cancer	2.39e-05	9.81e-05	CbGpPWpGaD
Dalfampridine—KCNQ2—Developmental Biology—AKT1—lung cancer	2.35e-05	9.66e-05	CbGpPWpGaD
Dalfampridine—KCNQ3—Developmental Biology—AKT1—lung cancer	2.35e-05	9.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CKB—lung cancer	2.34e-05	9.61e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—EP300—lung cancer	2.27e-05	9.36e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CNDP2—lung cancer	2.2e-05	9.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM2—lung cancer	2.2e-05	9.03e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—MTMR3—lung cancer	2.14e-05	8.79e-05	CbGpPWpGaD
Dalfampridine—KCNH2—Neuronal System—HRAS—lung cancer	2.09e-05	8.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PGAM1—lung cancer	2.08e-05	8.56e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2A7—lung cancer	1.99e-05	8.17e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—SDC4—lung cancer	1.94e-05	7.99e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—PIK3CA—lung cancer	1.77e-05	7.3e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—PIK3CA—lung cancer	1.77e-05	7.3e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—PIK3CA—lung cancer	1.77e-05	7.3e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—RRM1—lung cancer	1.77e-05	7.28e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA3—lung cancer	1.77e-05	7.28e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—PIK3CA—lung cancer	1.68e-05	6.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—B4GALT5—lung cancer	1.66e-05	6.85e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA4—lung cancer	1.62e-05	6.66e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA2—lung cancer	1.58e-05	6.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTA1—lung cancer	1.52e-05	6.26e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCC3—lung cancer	1.51e-05	6.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKR1C1—lung cancer	1.46e-05	6e-05	CbGpPWpGaD
Dalfampridine—KCNG2—Metabolism—AKT1—lung cancer	1.45e-05	5.96e-05	CbGpPWpGaD
Dalfampridine—KCNC2—Metabolism—AKT1—lung cancer	1.45e-05	5.96e-05	CbGpPWpGaD
Dalfampridine—KCNS3—Metabolism—AKT1—lung cancer	1.45e-05	5.96e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—UGT1A1—lung cancer	1.42e-05	5.82e-05	CbGpPWpGaD
Dalfampridine—KCNB1—Metabolism—AKT1—lung cancer	1.37e-05	5.65e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GNG11—lung cancer	1.36e-05	5.61e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALDOA—lung cancer	1.3e-05	5.34e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NCOA3—lung cancer	1.26e-05	5.19e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ADCY1—lung cancer	1.23e-05	5.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCG2—lung cancer	1.23e-05	5.05e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—HPGDS—lung cancer	1.2e-05	4.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO2—lung cancer	1.2e-05	4.95e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PPP2R1B—lung cancer	1.2e-05	4.92e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTT1—lung cancer	1.17e-05	4.8e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GCLC—lung cancer	1.15e-05	4.75e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP2A6—lung cancer	1.15e-05	4.75e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ENO1—lung cancer	1.09e-05	4.5e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—NQO1—lung cancer	9.7e-06	3.99e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—STK11—lung cancer	8.74e-06	3.6e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTP1—lung cancer	8.09e-06	3.33e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CAT—lung cancer	7.87e-06	3.24e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ABCB1—lung cancer	7.66e-06	3.15e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—TYMS—lung cancer	7.52e-06	3.09e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—GSTM1—lung cancer	7.43e-06	3.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CYP1A1—lung cancer	7.05e-06	2.9e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ERCC2—lung cancer	6.99e-06	2.88e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—APOA1—lung cancer	6.05e-06	2.49e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CG—lung cancer	5.52e-06	2.27e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—POMC—lung cancer	5.25e-06	2.16e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—CREBBP—lung cancer	5.12e-06	2.11e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CD—lung cancer	4.85e-06	2e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—ALB—lung cancer	4.79e-06	1.97e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CB—lung cancer	4.23e-06	1.74e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTGS2—lung cancer	4.19e-06	1.72e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PTEN—lung cancer	3.66e-06	1.5e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—EP300—lung cancer	3.49e-06	1.43e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—PIK3CA—lung cancer	2.58e-06	1.06e-05	CbGpPWpGaD
Dalfampridine—CYP2E1—Metabolism—AKT1—lung cancer	2.11e-06	8.66e-06	CbGpPWpGaD
